APO Research
Talk to an analyst

APO RESEARCH · REPORT

Opioids Drug

Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.

Selected research

Industry Growth & Trends

Global Opioids Drug Industry Growth and Trends Forecast to 2032

21 December 2025107 pages

Choose your research edition.

Industry ResearchOpioids Drug Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Opioids Drug Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Opioids Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Opioids Drug Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Opioids Drug Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.

Global Opioids Drug main players are Purdue Pharma, Teva, Pfizer, Hikma, etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share nearly 70%.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Opioids Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Opioids Drug market size, estimates, and forecasts are presented in terms of sales volume (M Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Opioids Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Opioids Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Opioids Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Opioids Drug Market by Company

Teva

Purdue Pharma

Mallinckrodt

Amneal Pharma

Collegium

J&J

Endo

Pfizer

INSYS

Mylan

Hikma

Egalet

Opioids Drug Segment by Type

Oxycodone

Hydromorphone

Codeine

Fentanyl

Opioids Drug Segment by Application

Pain Relief

Anesthesia

Others

Opioids Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioids Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Opioids Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioids Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Opioids Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Opioids Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oxycodone Table 2. Major Company of Hydromorphone Table 3. Major Company of Codeine Table 4. Major Company of Fentanyl Table 5. Global Opioids Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Opioids Drug Sales by Type (2021-2026) & (M Units) Table 7. Global Opioids Drug Sales Market Share in Volume by Type (2021-2026) Table 8. Global Opioids Drug Sales by Type (2021-2026) & (US$ Million) Table 9. Global Opioids Drug Sales Market Share in Value by Type (2021-2026) Table 10. Global Opioids Drug Price by Type (2021-2026) & (USD/Unit) Table 11. Global Opioids Drug Sales by Type (2027-2032) & (M Units) Table 12. Global Opioids Drug Sales Market Share in Volume by Type (2027-2032) Table 13. Global Opioids Drug Sales by Type (2027-2032) & (US$ Million) Table 14. Global Opioids Drug Sales Market Share in Value by Type (2027-2032) Table 15. Global Opioids Drug Price by Type (2027-2032) & (USD/Unit) Table 16. North America Opioids Drug Sales by Type (2021-2026) & (M Units) Table 17. North America Opioids Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Opioids Drug Sales by Type (2021-2026) & (M Units) Table 19. Europe Opioids Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Opioids Drug Sales by Type (2021-2026) & (M Units) Table 21. Asia-Pacific Opioids Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Opioids Drug Sales by Type (2021-2026) & (M Units) Table 23. Latin America Opioids Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Opioids Drug Sales by Type (2021-2026) & (M Units) Table 25. Middle East and Africa Opioids Drug Sales by Type (2021-2026) & (US$ Million) Table 26. Opioids Drug Industry Trends Table 27. Opioids Drug Industry Drivers Table 28. Opioids Drug Industry Opportunities and Challenges Table 29. Opioids Drug Industry Restraints Table 30. Global Opioids Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Opioids Drug Revenue Market Share by Company (2021-2026) Table 32. Global Opioids Drug Sales by Company (2021-2026) & (M Units) Table 33. Global Opioids Drug Sales Share by Company (2021-2026) Table 34. Global Opioids Drug Market Price by Company (2021-2026) & (USD/Unit) Table 35. Global Opioids Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Opioids Drug Major Company Production Sites and Headquarters Table 37. Global Opioids Drug Company, Product Type & Application Table 38. Global Opioids Drug Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Opioids Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Opioids Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Opioids Drug Sales by Region (2021-2026) & (M Units) Table 43. Global Opioids Drug Sales Market Share in Volume by Region (2021-2026) Table 44. Global Opioids Drug Sales by Region (2021-2026) & (US$ Million) Table 45. Global Opioids Drug Sales Market Share in Value by Region (2021-2026) Table 46. Global Opioids Drug Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 47. Global Opioids Drug Sales by Region (2027-2032) & (M Units) Table 48. Global Opioids Drug Sales Market Share in Volume by Region (2027-2032) Table 49. Global Opioids Drug Sales by Region (2027-2032) & (US$ Million) Table 50. Global Opioids Drug Sales Market Share in Value by Region (2027-2032) Table 51. Global Opioids Drug Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 52. Global Opioids Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Opioids Drug Sales by Application (2021-2026) & (M Units) Table 54. Global Opioids Drug Sales Market Share in Volume by Application (2021-2026) Table 55. Global Opioids Drug Sales by Application (2021-2026) & (US$ Million) Table 56. Global Opioids Drug Sales Market Share in Value by Application (2021-2026) Table 57. Global Opioids Drug Price by Application (2021-2026) & (USD/Unit) Table 58. Global Opioids Drug Sales by Application (2027-2032) & (M Units) Table 59. Global Opioids Drug Sales Market Share in Volume by Application (2027-2032) Table 60. Global Opioids Drug Sales by Application (2027-2032) & (US$ Million) Table 61. Global Opioids Drug Sales Market Share in Value by Application (2027-2032) Table 62. Global Opioids Drug Price by Application (2027-2032) & (USD/Unit) Table 63. North America Opioids Drug Sales by Application (2021-2026) & (M Units) Table 64. North America Opioids Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Opioids Drug Sales by Application (2021-2026) & (M Units) Table 66. Europe Opioids Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Opioids Drug Sales by Application (2021-2026) & (M Units) Table 68. Asia-Pacific Opioids Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Opioids Drug Sales by Application (2021-2026) & (M Units) Table 70. Latin America Opioids Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Opioids Drug Sales by Application (2021-2026) & (M Units) Table 72. Middle East and Africa Opioids Drug Sales by Application (2021-2026) & (US$ Million) Table 73. Teva Company Information Table 74. Teva Business Overview Table 75. Teva Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. Teva Opioids Drug Product Portfolio Table 77. Teva Recent Development Table 78. Purdue Pharma Company Information Table 79. Purdue Pharma Business Overview Table 80. Purdue Pharma Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. Purdue Pharma Opioids Drug Product Portfolio Table 82. Purdue Pharma Recent Development Table 83. Mallinckrodt Company Information Table 84. Mallinckrodt Business Overview Table 85. Mallinckrodt Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. Mallinckrodt Opioids Drug Product Portfolio Table 87. Mallinckrodt Recent Development Table 88. Amneal Pharma Company Information Table 89. Amneal Pharma Business Overview Table 90. Amneal Pharma Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. Amneal Pharma Opioids Drug Product Portfolio Table 92. Amneal Pharma Recent Development Table 93. Collegium Company Information Table 94. Collegium Business Overview Table 95. Collegium Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 96. Collegium Opioids Drug Product Portfolio Table 97. Collegium Recent Development Table 98. J&J Company Information Table 99. J&J Business Overview Table 100. J&J Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 101. J&J Opioids Drug Product Portfolio Table 102. J&J Recent Development Table 103. Endo Company Information Table 104. Endo Business Overview Table 105. Endo Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 106. Endo Opioids Drug Product Portfolio Table 107. Endo Recent Development Table 108. Pfizer Company Information Table 109. Pfizer Business Overview Table 110. Pfizer Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 111. Pfizer Opioids Drug Product Portfolio Table 112. Pfizer Recent Development Table 113. INSYS Company Information Table 114. INSYS Business Overview Table 115. INSYS Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 116. INSYS Opioids Drug Product Portfolio Table 117. INSYS Recent Development Table 118. Mylan Company Information Table 119. Mylan Business Overview Table 120. Mylan Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 121. Mylan Opioids Drug Product Portfolio Table 122. Mylan Recent Development Table 123. Hikma Company Information Table 124. Hikma Business Overview Table 125. Hikma Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 126. Hikma Opioids Drug Product Portfolio Table 127. Hikma Recent Development Table 128. Egalet Company Information Table 129. Egalet Business Overview Table 130. Egalet Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 131. Egalet Opioids Drug Product Portfolio Table 132. Egalet Recent Development Table 133. North America Opioids Drug Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 134. North America Opioids Drug Sales by Country (2021-2026) & (M Units) Table 135. North America Opioids Drug Sales Market Share by Country (2021-2026) Table 136. North America Opioids Drug Sales Forecast by Country (2027-2032) & (M Units) Table 137. North America Opioids Drug Sales Market Share Forecast by Country (2027-2032) Table 138. North America Opioids Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Opioids Drug Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Opioids Drug Market Share by Country (2021-2026) Table 141. North America Opioids Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Opioids Drug Market Share Forecast by Country (2027-2032) Table 143. Europe Opioids Drug Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 144. Europe Opioids Drug Sales by Country (2021-2026) & (M Units) Table 145. Europe Opioids Drug Sales Market Share by Country (2021-2026) Table 146. Europe Opioids Drug Sales Forecast by Country (2027-2032) & (M Units) Table 147. Europe Opioids Drug Sales Market Share Forecast by Country (2027-2032) Table 148. Europe Opioids Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Europe Opioids Drug Market Size by Country (2021-2026) & (US$ Million) Table 150. Europe Opioids Drug Market Share by Country (2021-2026) Table 151. Europe Opioids Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Europe Opioids Drug Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Opioids Drug Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Opioids Drug Sales by Country (2021-2026) & (M Units) Table 155. Asia-Pacific Opioids Drug Sales Market Share by Country (2021-2026) Table 156. Asia-Pacific Opioids Drug Sales Forecast by Country (2027-2032) & (M Units) Table 157. Asia-Pacific Opioids Drug Sales Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Opioids Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Opioids Drug Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Opioids Drug Market Share by Country (2021-2026) Table 161. Asia-Pacific Opioids Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Opioids Drug Market Share Forecast by Country (2027-2032) Table 163. Latin America Opioids Drug Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 164. Latin America Opioids Drug Sales by Country (2021-2026) & (M Units) Table 165. Latin America Opioids Drug Sales Market Share by Country (2021-2026) Table 166. Latin America Opioids Drug Sales Forecast by Country (2027-2032) & (M Units) Table 167. Latin America Opioids Drug Sales Market Share Forecast by Country (2027-2032) Table 168. Latin America Opioids Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America Opioids Drug Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America Opioids Drug Market Share by Country (2021-2026) Table 171. Latin America Opioids Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America Opioids Drug Market Share Forecast by Country (2027-2032) Table 173. Middle East and Africa Opioids Drug Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 174. Middle East and Africa Opioids Drug Sales by Country (2021-2026) & (M Units) Table 175. Middle East and Africa Opioids Drug Sales Market Share by Country (2021-2026) Table 176. Middle East and Africa Opioids Drug Sales Forecast by Country (2027-2032) & (M Units) Table 177. Middle East and Africa Opioids Drug Sales Market Share Forecast by Country (2027-2032) Table 178. Middle East and Africa Opioids Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Middle East and Africa Opioids Drug Market Size by Country (2021-2026) & (US$ Million) Table 180. Middle East and Africa Opioids Drug Market Share by Country (2021-2026) Table 181. Middle East and Africa Opioids Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Middle East and Africa Opioids Drug Market Share Forecast by Country (2027-2032) Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. Opioids Drug Distributors List Table 186. Opioids Drug Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. Opioids Drug Image Figure 2. Global Opioids Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Opioids Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Opioids Drug Sales (2021-2032) & (M Units) Figure 5. Oxycodone Image Figure 6. Global Oxycodone Sales YoY Growth (2021-2032) & (M Units) Figure 7. Hydromorphone Image Figure 8. Global Hydromorphone Sales YoY Growth (2021-2032) & (M Units) Figure 9. Codeine Image Figure 10. Global Codeine Sales YoY Growth (2021-2032) & (M Units) Figure 11. Fentanyl Image Figure 12. Global Fentanyl Sales YoY Growth (2021-2032) & (M Units) Figure 13. Global Opioids Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Opioids Drug Market Share by Type 2025 VS 2032 Figure 15. North America Opioids Drug Sales Market Share in Volume by Type in 2025 Figure 16. North America Opioids Drug Sales Market Share in Value by Type in 2025 Figure 17. Europe Opioids Drug Sales Market Share in Volume by Type in 2025 Figure 18. Europe Opioids Drug Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Opioids Drug Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Opioids Drug Sales Market Share in Value by Type in 2025 Figure 21. Latin America Opioids Drug Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Opioids Drug Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Opioids Drug Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Opioids Drug Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Opioids Drug Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Pain Relief Image Figure 28. Global Pain Relief Sales YoY Growth (2021-2032) & (M Units) Figure 29. Anesthesia Image Figure 30. Global Anesthesia Sales YoY Growth (2021-2032) & (M Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (M Units) Figure 33. Global Opioids Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Opioids Drug Market Share by Application 2025 VS 2032 Figure 35. North America Opioids Drug Sales Market Share in Volume by Application in 2025 Figure 36. North America Opioids Drug Sales Market Share in Value by Application in 2025 Figure 37. Europe Opioids Drug Sales Market Share in Volume by Application in 2025 Figure 38. Europe Opioids Drug Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Opioids Drug Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Opioids Drug Sales Market Share in Value by Application in 2025 Figure 41. Latin America Opioids Drug Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Opioids Drug Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Opioids Drug Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Opioids Drug Sales Market Share in Value by Application in 2025 Figure 45. North America Opioids Drug Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 46. North America Opioids Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Opioids Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Opioids Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Opioids Drug Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 50. Europe Opioids Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Opioids Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Opioids Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Opioids Drug Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 54. Asia-Pacific Opioids Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Opioids Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Opioids Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Opioids Drug Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 58. Latin America Opioids Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Opioids Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Opioids Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Opioids Drug Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 62. Middle East and Africa Opioids Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Opioids Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Opioids Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Opioids Drug Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Opioids Drug Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Oxycodone
  • Hydromorphone
  • Codeine
  • Fentanyl
Applications
  • Pain Relief
  • Anesthesia
  • Others
Companies covered
  • Teva
  • Purdue Pharma
  • Mallinckrodt
  • Amneal Pharma
  • Collegium
  • J&J
  • Endo
  • Pfizer
  • INSYS
  • Mylan
  • Hikma
  • Egalet

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Opioids Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Opioids Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Opioids Drug Market by Type
  6. 1.3.1 Oxycodone
  7. 1.3.2 Hydromorphone
  8. 1.3.3 Codeine
  9. 1.3.4 Fentanyl
  10. 1.4 Global Opioids Drug Market Size by Type
  11. 1.4.1 Global Opioids Drug Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Opioids Drug Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Opioids Drug Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Opioids Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Opioids Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Opioids Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Opioids Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Opioids Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Opioids Drug Industry Trends
  2. 2.2 Opioids Drug Industry Drivers
  3. 2.3 Opioids Drug Industry Opportunities and Challenges
  4. 2.4 Opioids Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Opioids Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Opioids Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Opioids Drug Price (2021-2026)
  4. 3.4 Global Opioids Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Opioids Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Opioids Drug Company, Product Type & Application
  7. 3.7 Global Opioids Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Opioids Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Opioids Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Opioids Drug Tier 1, Tier 2, and Tier 3
4 Opioids Drug Regional Status and Outlook
  1. 4.1 Global Opioids Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Opioids Drug Historic Market Size by Region
  3. 4.2.1 Global Opioids Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Opioids Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Opioids Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Opioids Drug Forecasted Market Size by Region
  7. 4.3.1 Global Opioids Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Opioids Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Opioids Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Opioids Drug by Application
  1. 5.1 Opioids Drug Market by Application
  2. 5.1.1 Pain Relief
  3. 5.1.2 Anesthesia
  4. 5.1.3 Others
  5. 5.2 Global Opioids Drug Market Size by Application
  6. 5.2.1 Global Opioids Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Opioids Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Opioids Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Opioids Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Opioids Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Opioids Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Opioids Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Opioids Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Opioids Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Opioids Drug Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Purdue Pharma
  8. 6.2.1 Purdue Pharma Company Information
  9. 6.2.2 Purdue Pharma Business Overview
  10. 6.2.3 Purdue Pharma Opioids Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Purdue Pharma Opioids Drug Product Portfolio
  12. 6.2.5 Purdue Pharma Recent Developments
  13. 6.3 Mallinckrodt
  14. 6.3.1 Mallinckrodt Company Information
  15. 6.3.2 Mallinckrodt Business Overview
  16. 6.3.3 Mallinckrodt Opioids Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mallinckrodt Opioids Drug Product Portfolio
  18. 6.3.5 Mallinckrodt Recent Developments
  19. 6.4 Amneal Pharma
  20. 6.4.1 Amneal Pharma Company Information
  21. 6.4.2 Amneal Pharma Business Overview
  22. 6.4.3 Amneal Pharma Opioids Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Amneal Pharma Opioids Drug Product Portfolio
  24. 6.4.5 Amneal Pharma Recent Developments
  25. 6.5 Collegium
  26. 6.5.1 Collegium Company Information
  27. 6.5.2 Collegium Business Overview
  28. 6.5.3 Collegium Opioids Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Collegium Opioids Drug Product Portfolio
  30. 6.5.5 Collegium Recent Developments
  31. 6.6 J&J
  32. 6.6.1 J&J Company Information
  33. 6.6.2 J&J Business Overview
  34. 6.6.3 J&J Opioids Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 J&J Opioids Drug Product Portfolio
  36. 6.6.5 J&J Recent Developments
  37. 6.7 Endo
  38. 6.7.1 Endo Company Information
  39. 6.7.2 Endo Business Overview
  40. 6.7.3 Endo Opioids Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Endo Opioids Drug Product Portfolio
  42. 6.7.5 Endo Recent Developments
  43. 6.8 Pfizer
  44. 6.8.1 Pfizer Company Information
  45. 6.8.2 Pfizer Business Overview
  46. 6.8.3 Pfizer Opioids Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Pfizer Opioids Drug Product Portfolio
  48. 6.8.5 Pfizer Recent Developments
  49. 6.9 INSYS
  50. 6.9.1 INSYS Company Information
  51. 6.9.2 INSYS Business Overview
  52. 6.9.3 INSYS Opioids Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 INSYS Opioids Drug Product Portfolio
  54. 6.9.5 INSYS Recent Developments
  55. 6.10 Mylan
  56. 6.10.1 Mylan Company Information
  57. 6.10.2 Mylan Business Overview
  58. 6.10.3 Mylan Opioids Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Mylan Opioids Drug Product Portfolio
  60. 6.10.5 Mylan Recent Developments
  61. 6.11 Hikma
  62. 6.11.1 Hikma Company Information
  63. 6.11.2 Hikma Business Overview
  64. 6.11.3 Hikma Opioids Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Hikma Opioids Drug Product Portfolio
  66. 6.11.5 Hikma Recent Developments
  67. 6.12 Egalet
  68. 6.12.1 Egalet Company Information
  69. 6.12.2 Egalet Business Overview
  70. 6.12.3 Egalet Opioids Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Egalet Opioids Drug Product Portfolio
  72. 6.12.5 Egalet Recent Developments
7 North America by Country
  1. 7.1 North America Opioids Drug Sales by Country
  2. 7.1.1 North America Opioids Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Opioids Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Opioids Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Opioids Drug Market Size by Country
  6. 7.2.1 North America Opioids Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Opioids Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Opioids Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Opioids Drug Sales by Country
  2. 8.1.1 Europe Opioids Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Opioids Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Opioids Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Opioids Drug Market Size by Country
  6. 8.2.1 Europe Opioids Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Opioids Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Opioids Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Opioids Drug Sales by Country
  2. 9.1.1 Asia-Pacific Opioids Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Opioids Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Opioids Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Opioids Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Opioids Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Opioids Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Opioids Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Opioids Drug Sales by Country
  2. 10.1.1 South America Opioids Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Opioids Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Opioids Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Opioids Drug Market Size by Country
  6. 10.2.1 South America Opioids Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Opioids Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Opioids Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Opioids Drug Sales by Country
  2. 11.1.1 Middle East and Africa Opioids Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Opioids Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Opioids Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Opioids Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Opioids Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Opioids Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Opioids Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Opioids Drug Value Chain Analysis
  2. 12.1.1 Opioids Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Opioids Drug Production Mode & Process
  7. 12.2 Opioids Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Opioids Drug Distributors
  10. 12.2.3 Opioids Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst